Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.77%
SPX
+0.83%
IXIC
+1.02%
FTSE
0.00%
N225
+0.06%
AXJO
+0.08%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
3.93M
Dividend Yield
0.00%
P/E Ratio
-0.37
EPS
-50.07
Revenue
-
Avg. Volume
253.95K

About

What does MBIO do?
Mustang Bio is a clinical-stage biopharmaceutical company based in Worcester, Massachusetts, focused on cell and gene therapies for cancers and genetic diseases, with partnerships for CAR-T and XSCID treatments. The company went public on August 22, 2017, and has 80 employees.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
New York, USA
Website
http://www.mustangbio.com

Recently from Cashu

publisher logo
Cashu

Mustang Bio: Request for Content to Summarize Unfulfilled.

1 day ago
Stocks
Health Care
mbio
Mustang Bio
MBIO
-0.05 (-4.03%)
1.19
USD
At close at Jul 04, 20:42 UTC
Summary
News
Signals
Benchmarks
Financials